Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA approves Kyowa Kirin’s Poteligeo to treat two lymphoma types

pharmaceutical-technologyAugust 13, 2018

Tag: FDA , lymphoma

PharmaSources Customer Service